Firetrail Investments stockpicker Eleanor Swanson on hunt for next success story

New Conference Manager Eleanor Swanson was instrumental in convincing the investment team at Firetrail Investments to buy into AfterPay.
Eleanor Swanson, a fund manager with Firetrail Investments, will be at the Sohn Hearts & Minds Conference in December. Picture: Jane Dempster

Glenda Korporaal

Firetrail Investments stockpicker Eleanor Swanson on hunt for next success story

November 15, 2021
New Conference Manager Eleanor Swanson was instrumental in convincing the investment team at Firetrail Investments to buy into AfterPay.
Read Transcript

Eleanor Swanson was having difficulty convincing the investment team to buy into Afterpay.

It was 2019, and Swanson, then 28, had just left Macquarie’s successful high conviction fund to set up a new shop – Firetrail Investments – with eight others.

And Afterpay, which had listed on the ASX just a year earlier, was far from the buy-now, pay later giant which would eventually be sold to American payments firm Square in a $39bn deal.

“It was the classic millennial thing … My friends were using it, we are more accustomed to shopping online,” Swanson says. “I said it was a fantastic company. I had experienced it first hand and was using it for shopping.

“But some of the older guys in the view took the view that it was a short-term bubble. They didn’t see it as having longevity.”

One colleague described the share price – $8 – as “crazy”.

After considerable discussion, Firetrail decided it was worth a closer look. In her internal pitch, Swanson argued Afterpay shares were worth at least $50.

“We looked at how the customer transacted on the platform,” she says. “The customer might use it twice in the first year, but by the time they have been on the platform for three years they are using it 20 times a year.

“The average value of the order was also increasing.

“When you put those two metrics together – the frequency of spend, and the average order, and assumed a growing penetration of the millennial market – we were getting an enormous upside.”

The pitch was convincing. Afterpay – and the investment along with it – become a major success.

Firetrail, with a small cap fund now worth some $300m, sold out when Afterpay’s share price rose above $90. Its hedge fund held on until it rose above $100.

Now Swanson will make her debut at Sohn Hearts & Minds in December – one of 16 stock pickers predicting the best equity plays for the year ahead.

An analyst at the small cap fund, Swanson’s remit stretches from healthcare to biotechs and industrial stocks. (Swanson, who has also worked as an analyst at JP Morgan, is the daughter of ClearView Wealth managing director Simon Swanson.)

For her Sohn conference pick – to be revealed on the day – she has chosen a small cap Australian company in the tech sector.

“It is playing into the global growth thematic,” she says.

“It is an Australian company which has built a product here and is now taking it offshore and building a global business.”

Firetrail’s small caps fund can take in companies with market capitalisations of more than $200m up to ASX 50 companies.

Swanson says the fund has a flexible approach to stock picking, looking for a combination of growth and value stocks.

“Our investment philosophy is that every company has a price,” she says. “We do have more of a bias to companies with earnings as we believe share prices follow earnings. But we are very happy to play in the growth part of the market … we see a company’s valuation as very important.

“We would never buy a company just because we liked the thematic or like the space.

“We always build a proper model and figure it out. We want to see if there is upside based on where we think the earnings will land relative to market expectations. One of our best stock picks has been where we have found an angle on a company the markets have not cottoned on to yet.”

Swanson cites Beacon Lighting as one of the fund’s successful small cap investments.

“Eighteen months ago, we cottoned on to the fact they were rolling out a trade strategy instead of just focusing on the retail market.

“It has been a great performer for the fund. Finding that angle gave us a great point of differentiation to model out the earnings.”

Swanson says a background in science has given her an insight into healthcare and biotech stocks. Her picks have included New Zealand wound care product company Aroa Biosurgery.

“It listed on the ASX about June last year and it was one of our top picks. We actually invested just before the IPO when it was hard for companies to get their hands on capital.

“We stepped up pre-IPO and then helped them underwrite the IPO a few months later. It has been a great performer for us.”

The fund’s favourite industrial stock at the moment is outdoor advertising company oOh!Media.

“We think the market is underestimating how strong the advertising market is going to be next year,” Swanson says.

“Australians have saved over $150bn during lockdowns, not being able to travel or go out to dinner and having benefited from stimulus payments.

“We think there is enormous pent-up demand and there are companies which will want to make sure they get their share of the pie.” She says oOh! Media has a big presence in airports, which she believes will benefit as Australians resume domestic travel.

“We think they are going to be flat to up on their revenue prior to Covid whereas the market is thinking they wont be able to get back to where they were in 2019.”

She also likes Ardent Leisure, the leisure and outdoor theme park company whose fortunes were hit by the tragedy at Dreamworld on the Gold Coast in 2016. Her analysis sees the company potentially generating earnings before interest and tax at $120m compared to its current $80m.

She believes its US leisure centres, which operate under the brand Main Event, are turning around and generating more revenue, becoming its main asset.

Swanson, whose short career in funds management has never seen a down market, says she has benefited from the rush of IPOs on the ASX in the past 18 months.

“It has been an incredibly hot market for IPOs,” she says.

“I have learned a huge amount in terms of how to do due diligence. You have to make sure you not only speak to the chief executive and the chief financial officer, but also talk to their customers and ex-employees to get a holistic view of a company.”

She says the fund takes a three-year view when it looks at whether to invest in an IPO.

“We are not going to jump into an IPO because we think it is going to go up 20 or 30 per cent on one day,” she says. “Our favourite company is one which is genuinely coming to the market because it has a huge growth opportunity and needs capital.

“It’s always a red flag if a company is coming to the market opportunistically for no reason, or driven by private equity or the founders wanting to get out.”

Swanson says she is more than happy concentrating on the small cap sector in Australia.

“There are so many fantastic companies acrossall parts of the market – outstanding resource companies, mining services, financial services.

“Our big cap team is excited if they find a company that has 30 per cent upside. But (at the small cap fund) we are excited to find a company which has 200 to 300 per cent upside. The opportunities are so much more elevated with small companies. We always have at least 20 stock ideas.”

The annual Sohn conference started in New York in 1995 to commemorate the life of Ira Sohn, a Wall Street fund manager who died at the age of 29 from cancer.

This year’s conference in Australia, online as a result of the Covid-19 pandemic, will feature a video appearance by Warren Buffett’s colleague, Charlie Munger. It will also hear from Caledonia Investments chairman Mark Nelson and Regal Funds chief investment officer Phil King.

The local conferences, which began in 2016 have raised more than $30m for medical research.

The Sohn Hearts & Minds Conference will be held on December 3.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Eleanor Swanson was having difficulty convincing the investment team to buy into Afterpay.

It was 2019, and Swanson, then 28, had just left Macquarie’s successful high conviction fund to set up a new shop – Firetrail Investments – with eight others.

And Afterpay, which had listed on the ASX just a year earlier, was far from the buy-now, pay later giant which would eventually be sold to American payments firm Square in a $39bn deal.

“It was the classic millennial thing … My friends were using it, we are more accustomed to shopping online,” Swanson says. “I said it was a fantastic company. I had experienced it first hand and was using it for shopping.

“But some of the older guys in the view took the view that it was a short-term bubble. They didn’t see it as having longevity.”

One colleague described the share price – $8 – as “crazy”.

After considerable discussion, Firetrail decided it was worth a closer look. In her internal pitch, Swanson argued Afterpay shares were worth at least $50.

“We looked at how the customer transacted on the platform,” she says. “The customer might use it twice in the first year, but by the time they have been on the platform for three years they are using it 20 times a year.

“The average value of the order was also increasing.

“When you put those two metrics together – the frequency of spend, and the average order, and assumed a growing penetration of the millennial market – we were getting an enormous upside.”

The pitch was convincing. Afterpay – and the investment along with it – become a major success.

Firetrail, with a small cap fund now worth some $300m, sold out when Afterpay’s share price rose above $90. Its hedge fund held on until it rose above $100.

Now Swanson will make her debut at Sohn Hearts & Minds in December – one of 16 stock pickers predicting the best equity plays for the year ahead.

An analyst at the small cap fund, Swanson’s remit stretches from healthcare to biotechs and industrial stocks. (Swanson, who has also worked as an analyst at JP Morgan, is the daughter of ClearView Wealth managing director Simon Swanson.)

For her Sohn conference pick – to be revealed on the day – she has chosen a small cap Australian company in the tech sector.

“It is playing into the global growth thematic,” she says.

“It is an Australian company which has built a product here and is now taking it offshore and building a global business.”

Firetrail’s small caps fund can take in companies with market capitalisations of more than $200m up to ASX 50 companies.

Swanson says the fund has a flexible approach to stock picking, looking for a combination of growth and value stocks.

“Our investment philosophy is that every company has a price,” she says. “We do have more of a bias to companies with earnings as we believe share prices follow earnings. But we are very happy to play in the growth part of the market … we see a company’s valuation as very important.

“We would never buy a company just because we liked the thematic or like the space.

“We always build a proper model and figure it out. We want to see if there is upside based on where we think the earnings will land relative to market expectations. One of our best stock picks has been where we have found an angle on a company the markets have not cottoned on to yet.”

Swanson cites Beacon Lighting as one of the fund’s successful small cap investments.

“Eighteen months ago, we cottoned on to the fact they were rolling out a trade strategy instead of just focusing on the retail market.

“It has been a great performer for the fund. Finding that angle gave us a great point of differentiation to model out the earnings.”

Swanson says a background in science has given her an insight into healthcare and biotech stocks. Her picks have included New Zealand wound care product company Aroa Biosurgery.

“It listed on the ASX about June last year and it was one of our top picks. We actually invested just before the IPO when it was hard for companies to get their hands on capital.

“We stepped up pre-IPO and then helped them underwrite the IPO a few months later. It has been a great performer for us.”

The fund’s favourite industrial stock at the moment is outdoor advertising company oOh!Media.

“We think the market is underestimating how strong the advertising market is going to be next year,” Swanson says.

“Australians have saved over $150bn during lockdowns, not being able to travel or go out to dinner and having benefited from stimulus payments.

“We think there is enormous pent-up demand and there are companies which will want to make sure they get their share of the pie.” She says oOh! Media has a big presence in airports, which she believes will benefit as Australians resume domestic travel.

“We think they are going to be flat to up on their revenue prior to Covid whereas the market is thinking they wont be able to get back to where they were in 2019.”

She also likes Ardent Leisure, the leisure and outdoor theme park company whose fortunes were hit by the tragedy at Dreamworld on the Gold Coast in 2016. Her analysis sees the company potentially generating earnings before interest and tax at $120m compared to its current $80m.

She believes its US leisure centres, which operate under the brand Main Event, are turning around and generating more revenue, becoming its main asset.

Swanson, whose short career in funds management has never seen a down market, says she has benefited from the rush of IPOs on the ASX in the past 18 months.

“It has been an incredibly hot market for IPOs,” she says.

“I have learned a huge amount in terms of how to do due diligence. You have to make sure you not only speak to the chief executive and the chief financial officer, but also talk to their customers and ex-employees to get a holistic view of a company.”

She says the fund takes a three-year view when it looks at whether to invest in an IPO.

“We are not going to jump into an IPO because we think it is going to go up 20 or 30 per cent on one day,” she says. “Our favourite company is one which is genuinely coming to the market because it has a huge growth opportunity and needs capital.

“It’s always a red flag if a company is coming to the market opportunistically for no reason, or driven by private equity or the founders wanting to get out.”

Swanson says she is more than happy concentrating on the small cap sector in Australia.

“There are so many fantastic companies acrossall parts of the market – outstanding resource companies, mining services, financial services.

“Our big cap team is excited if they find a company that has 30 per cent upside. But (at the small cap fund) we are excited to find a company which has 200 to 300 per cent upside. The opportunities are so much more elevated with small companies. We always have at least 20 stock ideas.”

The annual Sohn conference started in New York in 1995 to commemorate the life of Ira Sohn, a Wall Street fund manager who died at the age of 29 from cancer.

This year’s conference in Australia, online as a result of the Covid-19 pandemic, will feature a video appearance by Warren Buffett’s colleague, Charlie Munger. It will also hear from Caledonia Investments chairman Mark Nelson and Regal Funds chief investment officer Phil King.

The local conferences, which began in 2016 have raised more than $30m for medical research.

The Sohn Hearts & Minds Conference will be held on December 3.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Nov 15, 2021. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 27, 2023

The imaginary nepotism that drives Carsales global growth

The long-term approach of Carsales (2022 Conference stock pick) and its CEO Cameron McIntyre has delivered big gains for investors. He reveals his secret to staying strategic.

Read More
March 12, 2023

Jun Bei Liu is not giving up on the China reopening theme

Tribeca’s Jun Bei Liu says China’s reopening is only getting started, and names five ASX stocks set to benefit.

Read More
January 18, 2023

Claremont Global: Investment Case for Nike

Equity Mates are joined by Head of Claremont Global Bob Desmond to discuss his 2022 conference pick, Nike. In the episode Bob unpacks the key metrics, the bull case and the bear case for Nike.

Read More
January 5, 2023

Why Transurban will always be one step ahead of inflation

Loathed by motorists, but loved by investors. Transurban came under focus when Catherine Allfrey nominated the roads operator as her top pick at the recent Sohn Hearts & Minds Conference.

Read More
November 18, 2022

Behind the mega-themes shaping top stockpickers

These are the mega-themes the smartest minds in the market are now firmly getting behind which they believe can help them deliver outsized profits.

Read More
November 18, 2022

Don’t rush to invest yet, fund manager tells Sohn event

Fund manager turned anti-corruption campaigner Bill Browder is advising investors to hang on to their cash until central banks stop raising interest rates and the cost of living starts to come down.

Read More
November 18, 2022

Fund managers go global for top Sohn conference stock picks over Aussie companies

SH&M had before Friday’s event made more than $40m in collective donations to medical research.

Read More
November 18, 2022

Fundies and billionaires party in Hobart

Two hundred of Australia’s best and brightest money managers, bankers and entrepreneurs toasted the seventh Sohn Hearts and Minds conference at David Walsh’s MONA.

Read More
November 18, 2022

Hearts racing: Rich listers rendezvous for speed-dating style stock picking

A room filled with 700 of the country’s financial luminaries and billionaires is a difficult place to pitch an investment idea but it’s a great place to raise money for charity.

Read More
November 18, 2022

How MONA’s David Walsh shocked our top stock pickers

Professional gambler and arts impresario David Walsh had a brutal message for successful top money managers – you may just be lucky.

Read More
November 18, 2022

Why Sohn’s top stock pickers want investors to play it safe

Top global money managers are telling investors to steer clear of companies that don’t make money and invest instead in unloved but profitable businesses.

Read More
November 17, 2022

Five years on, what are the best Sohn stock picks to date?

Some of the top fund managers in the country will on Friday pitch their best investment ideas to the Sohn Hearts & Minds conference.

Read More
November 17, 2022

Low debt counts for everything, says Perpetual’s Aboud

Perpetual’s top stock picker Anthony Aboud makes his money running against the crowd and this is why property trusts like Charter Hall are sitting right the top his list right now.

Read More
November 17, 2022

Perpetual’s Aboud says bet on balance sheets in turbulent markets

Perpetual’s Anthony Aboud says companies with strong balance sheets will finally be rewarded for their discipline in a time of global market upheaval.

Read More
November 16, 2022

How Gerry Cardinale of RedBird Capital tries to double his money investing in sport

The owner of AC Milan and a host of other soccer, cricket, baseball and ice hockey assets is trying to double his money in the ‘resilient’ asset class.

Read More
December 10, 2024

Professor Jane Butler: Sparking Hope for Spinal Cord Injuries

In this episode of the Hearts & Minds Podcast, we sit down with Professor Jane Butler to discuss her groundbreaking research into spinal cord injuries.

Read More
impact-podcasts
September 24, 2024

Asian Market Potential with Tom Naughton of Prusik

CIO Charlie Lanchester sits down with Tom Naughton, CIO of Prusik Investment Mgmt. Tom shares his investment philosophy, the opportunities and challenges in Asian markets, and how his 2023 conference stock pick, Swire Pacific (0019.HK), delivered an impressive 30% return.

Read More
investing
September 4, 2024

Building Hearts and Minds with Co-Founders Matthew Grounds and Guy Fowler

In this episode, co-founders Matthew Grounds AM and Guy Fowler OAM discuss their journey in building Hearts & Minds and its philanthropic model that has donated over $70 million to medical research.

Read More
investing
June 25, 2024

Navigating the Resource Sector with Jeremy Bond of Terra Capital

In this episode, we chat with Jeremy Bond, Founder of Terra Capital and HM1 Conference Fund Manager. Tune in for insights into the world of resource investments and the exciting opportunities that lie ahead.

Read More
investing
June 11, 2024

Prof. Nadia Badawi on Cerebral Palsy Breakthroughs and Neonatal Care

Dive deep into the groundbreaking work of Professor Nadia Badawi, an internationally recognised neonatologist and expert in Cerebral Palsy.

Read More
impact-podcasts
May 28, 2024

Investment Insights: Rikki Bannan on Top Picks and Trends

Join us for an engaging episode featuring Rikki Bannan, Portfolio Manager of IFM Investors and HM1 Conference Fund Manager. This episode explores Rikki's career journey, investment strategies, and her 2023 conference stock pick, Telix Pharmaceuticals (ASX.TLX).

Read More
investing
December 6, 2023

Peter Cooper talks building and instilling a culture of humility and excellence

In this episode, our guest is the renowned investor, Peter Cooper, founder and Chief Investment Officer of Cooper Investors (Core Fund Manager). A founding supporter of Hearts and Minds, Peter is a staunch advocate of our model and its philanthropic purpose, actively engaging in every facet of Hearts and Minds.

Read More
investing
November 28, 2023

Jun Bei Liu on her high conviction investment strategy

In this episode, HM1 Chief Investment Officer Charlie Lanchester is joined by Jun Bei Liu. Jun Bei is the Portfolio Manager of Tribeca’s Alpha Plus Fund and since taking over managing the Fund, she has quadrupled AUM.

Read More
investing
November 21, 2023

The world of rare genetic disease research

In this episode, we speak to Associate Professor Gina Ravenscroft. Gina is an Associate Professor in Neurogenetics at the Harry Perkins Institute of Medical Research in Perth. Her research interests are in rare genetic diseases, with a particular focus on neurogenetic diseases in babies and children.

Read More
impact-podcasts
November 14, 2023

Learn what makes a high conviction investment and how to avoid short-term noise

In this episode, our Core Fund Manager Magellan shares how they select top stocks for the HM1 portfolio.

Read More
investing
November 7, 2023

Delve into the world of kids critical care and trauma research

In thie episode, we are joined by Dr. Marino Festa, or Rino for short. He is the Medical Director of NSW Kids ECMO Referral Service and a senior specialist in Paediatric Intensive Care at Children’s Hospital at Westmead.

Read More
impact-podcasts
October 31, 2023

Where Regal's Phil King is searching for opportunities

HM1's CIO, Charlie Lanchester, talks to Phil King of Regal Funds about his passion for stocks, his ongoing search for opportunities, and some of the sectors he’s excited by right now. Phil King of Regal Funds, has been a tremendous supporter of Hearts & Minds since the beginning.

Read More
investing
October 24, 2023

Preventing recurrent miscarriages and birth defects

In this episode, CEO Paul Rayson is joined by renowned biomedical researcher Professor Sally Dunwoodie. Prof. Dunwoodie's groundbreaking work has revolutionised clinical practices and enabled genetic diagnostic tests worldwide. In 2017, her team achieved a double breakthrough with the potential to prevent recurrent miscarriages and various birth defects.

Read More
impact-podcasts
October 17, 2023

Nick Griffin on how he finds global winners

In this episode, CIO Charlie Lanchester chats with Nick Griffin, the founding partner and CIO of Munro Partners, one of HM1's Core Fund Managers. They go over his career to date, reflect on the lessons he’s learned, and trace the decisions that led to him starting Munro.

Read More
investing
October 10, 2023

How A/Prof Matt Call is teaching our body to kill cancer

In this episode, CEO Paul Rayson is joined by WEHI’s Associate Professor Matt Call to talk about his incredible research. Matt’s team teaches and trains the body's own immune cells to target and kill cancer cells.

Read More
impact-podcasts

No results found.

Please try a different search keyword or filter.